Prosecution Insights
Last updated: April 19, 2026

Natco Pharma Limited

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18568160 EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER PIHONAK, SARAH 1627 Non-Final OA Dec 07, 2023
18261213 PHARMACEUTICAL COMPOSITIONS COMPRISING ACALABRUTINIB WORSHAM, JESSICA N 1615 Final Rejection Jul 12, 2023

Managing Natco Pharma Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month